The T lymphoblastic malignancies L. M. NadlerE. L. ReinherzS. F. Schlossman General Reviews Pages: 11 - 15
Oncostatic-antibody complexes in chemotherapy H. F. J. DullensR. A. De Weger Short Review Pages: 29 - 32
A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma G. FalksonD. Von HoffP. P. Carbone Original Articles Pages: 33 - 36
Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer G. BonadonnaPinuccia ValagussaG. Di Fronzo Original Articles Pages: 37 - 41
Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer R. D. RubensR. J. B. KingJ. L. Hayward Original Articles Pages: 43 - 45
Rapid plasma clearance and reduced rate and extent of urinary elimination of parenterally administered methotrexate as a result of severe vomiting and diarrhoea H. W. Van Den BergR. F. MurphyD. G. Kennedy Original Articles Pages: 47 - 48
Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl)phosphinate (AB-163) G. L. WamplerM. KupermincW. Regelson Original Articles Pages: 49 - 52
Microcinematographic study on the effect of methotrexate upon mouse mammary tumor cells (MMT cell line) Y. Alvarez-RodríguezAlicia RuanoY. Valladares Original Articles Pages: 53 - 60
Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid M. F. BrañaJ. M. CastellanoA. Jiménez Original Articles Pages: 61 - 66
Meeting announcement EORTC Symposium on Treatment of Neoplastic Lesions of the Nervous System Institut Jules Bordet, Brussels, April 10–11, 1980 Announcement Pages: A3 - A3
